About Oasis Diagnostics
Oasis Diagnostics is a company based in Vancouver (United States) founded in 2002. Oasis Diagnostics operates in a competitive market with competitors including ArcherDX, Qiagen, Devyser, Third Wave Technologies and DxTerity, among others.
- Headquarter Vancouver, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Meridian Bioscience
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Oasis Diagnostics
Investors in Oasis Diagnostics
Oasis Diagnostics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Meridian Bioscience, NIH and The Michael J. Fox Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Molecular diagnostic device and kits
|
Locked | Locked | Locked |
Investor details for Oasis Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oasis Diagnostics
Investment portfolio details for Oasis Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oasis Diagnostics
Detailed financials for Oasis Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oasis Diagnostics Comparisons
Peer comparison for Oasis Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oasis Diagnostics
Oasis Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Qiagen, Devyser, Third Wave Technologies and DxTerity, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| Locked | Locked | Locked |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
|
| Locked | Locked | Locked |
Molecular diagnostic devices and reagents are developed and marketed.
|
|
| Locked | Locked | Locked |
Provider of a direct-to-consumer, non-clinical genetic tests
|
|
| Locked | Locked | Locked |
Molecular diagnostic kits for infectious diseases are developed and manufactured.
|
Detailed competitors of Oasis Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oasis Diagnostics
Complete news archive for Oasis Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oasis Diagnostics
Oasis Diagnostics was founded in 2002 and raised its 1st funding round 7 years after it was founded.
Oasis Diagnostics is headquartered in Vancouver, United States. It is registered at Vancouver, Washington, United States.
Oasis Diagnostics is engaged in development and marketing of non-invasive saliva-based technology for rapid testing, sample collection, and molecular diagnostics DNA, RNA and proteins. Its products Versi SAL is a standardized whole saliva collection tool, UltraSal-2 for large volume oral specimen collection and SuperSAM saliva collection device for universal saliva collection purposes. The company is focused on developing tools for specific applications in the areas of stress, dehydration, drugs of abuse, infectious diseases (including HIV and tuberculosis), steroid hormones, oncology, Alzheimers disease and Parkinsons disease.
Oasis Diagnostics has 5 investors. Key investors include Meridian Bioscience, NIH, The Michael J. Fox Foundation, GHIT Fund, and ZINO Society.